| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 15.711 | 47.187 | 57.724 | 64.180 | 65.350 | 69.785 | 72.479 | 81.560 | 89.209 |
| Total Income - EUR | - | 15.711 | 47.187 | 57.725 | 64.180 | 68.470 | 69.785 | 72.479 | 81.568 | 89.209 |
| Total Expenses - EUR | - | 12.443 | 29.277 | 36.358 | 43.363 | 55.325 | 39.904 | 42.374 | 46.478 | 45.819 |
| Gross Profit/Loss - EUR | - | 3.268 | 17.910 | 21.366 | 20.818 | 13.145 | 29.881 | 30.105 | 35.089 | 43.390 |
| Net Profit/Loss - EUR | - | 3.110 | 16.683 | 20.789 | 20.166 | 12.740 | 29.197 | 29.395 | 34.290 | 40.714 |
| Employees | - | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 4 |
Check the financial reports for the company - Sanoderma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 187 | 19.387 | 14.553 | 21.495 | 14.582 | 8.375 | 7.596 | 5.136 | 2.680 |
| Current Assets | - | 4.714 | 18.984 | 24.583 | 14.973 | 9.197 | 26.078 | 24.099 | 31.735 | 39.798 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 16.927 | 22.341 | 7.150 | 4.450 | 17.924 | 10.292 | 26.386 | 20.743 |
| Cash | - | 4.714 | 2.057 | 2.242 | 7.823 | 4.748 | 8.154 | 13.807 | 5.349 | 19.055 |
| Shareholders Funds | - | 3.144 | 16.753 | 20.841 | 20.217 | 12.790 | 29.246 | 29.444 | 34.339 | 40.762 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.758 | 21.618 | 18.295 | 16.251 | 10.989 | 5.208 | 2.251 | 2.532 | 1.716 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sanoderma Srl